COVID-19 Outbreak-Global Hypertension Drugs Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020

Publisher Name :
Date: 30-Jun-2020
No. of pages: 130

Antihypertensive drugs are a class of drugs used to treat high blood pressure (hypertension).

The Hypertension Drugs market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.

Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.

In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Hypertension Drugs industry.

Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.

In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.

The Hypertension Drugs market can be split based on product types, major applications, and important countries as follows:

Key players in the global Hypertension Drugs market covered in Chapter 12:

Pfizer Inc.

XOMA LLC

Valeant Pharmaceuticals International Inc.

Daiichi Sankyo Co. Ltd.

Merck & Co. Inc

Boehringer Ingelheim GmbH

Bayer HealthCare

Sun Pharmaceutical Industries

Forest Laboratories Inc

Sanofi SA

Takeda Pharmaceuticals

Actelion Ltd

United Therapeutics Corp.

Bayer AG

Takeda Pharmaceutical Co. Ltd.

LG Life Sciences

Johnson & Johnson

AstraZeneca plc

Lupin Pharmaceuticals

Novartis AG

Beijing Tongrentang

In Chapter 4 and 14.1, on the basis of types, the Hypertension Drugs market from 2015 to 2025 is primarily split into:

Calcium Channel Blockers

Diuretics

Beta Blockers Vasodilators

Angiotensin Converting Enzyme Inhibitors

Alpha Blockers

Angiotensin Receptor Blockers

Renin Inhibitors

In Chapter 5 and 14.2, on the basis of applications, the Hypertension Drugs market from 2015 to 2025 covers:

Hospital use

Clinic use

Household

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:

North America (Covered in Chapter 7 and 14)

United States

Canada

Mexico

Europe (Covered in Chapter 8 and 14)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 9 and 14)

China

Japan

South Korea

Australia

India

Southeast Asia

Others

Middle East and Africa (Covered in Chapter 10 and 14)

Saudi Arabia

UAE

Egypt

Nigeria

South Africa

Others

South America (Covered in Chapter 11 and 14)

Brazil

Argentina

Columbia

Chile

Others

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2025

COVID-19 Outbreak-Global Hypertension Drugs Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020

Table of Content

1 Hypertension Drugs Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Hypertension Drugs
1.3 Scope of The Study
1.3.1 Key Market Segments
1.3.2 Players Covered
1.3.3 COVID-19's impact on the Hypertension Drugs industry
1.4 Methodology of The Study
1.5 Research Data Source

2 Executive Summary
2.1 Market Overview
2.1.1 Global Hypertension Drugs Market Size, 2015 - 2020
2.1.2 Global Hypertension Drugs Market Size by Type, 2015 - 2020
2.1.3 Global Hypertension Drugs Market Size by Application, 2015 - 2020
2.1.4 Global Hypertension Drugs Market Size by Region, 2015 - 2025
2.2 Business Environment Analysis
2.2.1 Global COVID-19 Status and Economic Overview
2.2.2 Influence of COVID-19 Outbreak on Hypertension Drugs Industry Development

3 Industry Chain Analysis
3.1 Upstream Raw Material Suppliers of Hypertension Drugs Analysis
3.2 Major Players of Hypertension Drugs
3.3 Hypertension Drugs Manufacturing Cost Structure Analysis
3.3.1 Production Process Analysis
3.3.2 Manufacturing Cost Structure of Hypertension Drugs
3.3.3 Labor Cost of Hypertension Drugs
3.4 Market Distributors of Hypertension Drugs
3.5 Major Downstream Buyers of Hypertension Drugs Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally

4 Global Hypertension Drugs Market, by Type
4.1 Global Hypertension Drugs Value and Market Share by Type (2015-2020)
4.2 Global Hypertension Drugs Production and Market Share by Type (2015-2020)
4.3 Global Hypertension Drugs Value and Growth Rate by Type (2015-2020)
4.3.1 Global Hypertension Drugs Value and Growth Rate of Calcium Channel Blockers
4.3.2 Global Hypertension Drugs Value and Growth Rate of Diuretics
4.3.3 Global Hypertension Drugs Value and Growth Rate of Beta Blockers Vasodilators
4.3.4 Global Hypertension Drugs Value and Growth Rate of Angiotensin Converting Enzyme Inhibitors
4.3.5 Global Hypertension Drugs Value and Growth Rate of Alpha Blockers
4.3.6 Global Hypertension Drugs Value and Growth Rate of Angiotensin Receptor Blockers
4.3.7 Global Hypertension Drugs Value and Growth Rate of Renin Inhibitors
4.4 Global Hypertension Drugs Price Analysis by Type (2015-2020)

5 Hypertension Drugs Market, by Application
5.1 Downstream Market Overview
5.2 Global Hypertension Drugs Consumption and Market Share by Application (2015-2020)
5.3 Global Hypertension Drugs Consumption and Growth Rate by Application (2015-2020)
5.3.1 Global Hypertension Drugs Consumption and Growth Rate of Hospital use (2015-2020)
5.3.2 Global Hypertension Drugs Consumption and Growth Rate of Clinic use (2015-2020)
5.3.3 Global Hypertension Drugs Consumption and Growth Rate of Household (2015-2020)

6 Global Hypertension Drugs Market Analysis by Regions
6.1 Global Hypertension Drugs Sales, Revenue and Market Share by Regions
6.1.1 Global Hypertension Drugs Sales by Regions (2015-2020)
6.1.2 Global Hypertension Drugs Revenue by Regions (2015-2020)
6.2 North America Hypertension Drugs Sales and Growth Rate (2015-2020)
6.3 Europe Hypertension Drugs Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Hypertension Drugs Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Hypertension Drugs Sales and Growth Rate (2015-2020)
6.6 South America Hypertension Drugs Sales and Growth Rate (2015-2020)

7 North America Hypertension Drugs Market Analysis by Countries
7.1 The Influence of COVID-19 on North America Market
7.2 North America Hypertension Drugs Sales, Revenue and Market Share by Countries
7.2.1 North America Hypertension Drugs Sales by Countries (2015-2020)
7.2.2 North America Hypertension Drugs Revenue by Countries (2015-2020)
7.3 United States Hypertension Drugs Sales and Growth Rate (2015-2020)
7.4 Canada Hypertension Drugs Sales and Growth Rate (2015-2020)
7.5 Mexico Hypertension Drugs Sales and Growth Rate (2015-2020)

8 Europe Hypertension Drugs Market Analysis by Countries
8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Hypertension Drugs Sales, Revenue and Market Share by Countries
8.2.1 Europe Hypertension Drugs Sales by Countries (2015-2020)
8.2.2 Europe Hypertension Drugs Revenue by Countries (2015-2020)
8.3 Germany Hypertension Drugs Sales and Growth Rate (2015-2020)
8.4 UK Hypertension Drugs Sales and Growth Rate (2015-2020)
8.5 France Hypertension Drugs Sales and Growth Rate (2015-2020)
8.6 Italy Hypertension Drugs Sales and Growth Rate (2015-2020)
8.7 Spain Hypertension Drugs Sales and Growth Rate (2015-2020)
8.8 Russia Hypertension Drugs Sales and Growth Rate (2015-2020)

9 Asia Pacific Hypertension Drugs Market Analysis by Countries
9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Hypertension Drugs Sales, Revenue and Market Share by Countries
9.2.1 Asia Pacific Hypertension Drugs Sales by Countries (2015-2020)
9.2.2 Asia Pacific Hypertension Drugs Revenue by Countries (2015-2020)
9.3 China Hypertension Drugs Sales and Growth Rate (2015-2020)
9.4 Japan Hypertension Drugs Sales and Growth Rate (2015-2020)
9.5 South Korea Hypertension Drugs Sales and Growth Rate (2015-2020)
9.6 India Hypertension Drugs Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Hypertension Drugs Sales and Growth Rate (2015-2020)
9.8 Australia Hypertension Drugs Sales and Growth Rate (2015-2020)

10 Middle East and Africa Hypertension Drugs Market Analysis by Countries
10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Hypertension Drugs Sales, Revenue and Market Share by Countries
10.2.1 Middle East and Africa Hypertension Drugs Sales by Countries (2015-2020)
10.2.2 Middle East and Africa Hypertension Drugs Revenue by Countries (2015-2020)
10.3 Saudi Arabia Hypertension Drugs Sales and Growth Rate (2015-2020)
10.4 UAE Hypertension Drugs Sales and Growth Rate (2015-2020)
10.5 Egypt Hypertension Drugs Sales and Growth Rate (2015-2020)
10.6 Nigeria Hypertension Drugs Sales and Growth Rate (2015-2020)
10.7 South Africa Hypertension Drugs Sales and Growth Rate (2015-2020)

11 South America Hypertension Drugs Market Analysis by Countries
11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Hypertension Drugs Sales, Revenue and Market Share by Countries
11.2.1 South America Hypertension Drugs Sales by Countries (2015-2020)
11.2.2 South America Hypertension Drugs Revenue by Countries (2015-2020)
11.3 Brazil Hypertension Drugs Sales and Growth Rate (2015-2020)
11.4 Argentina Hypertension Drugs Sales and Growth Rate (2015-2020)
11.5 Columbia Hypertension Drugs Sales and Growth Rate (2015-2020)
11.6 Chile Hypertension Drugs Sales and Growth Rate (2015-2020)

12 Competitive Landscape
12.1 Pfizer Inc.
12.1.1 Pfizer Inc. Basic Information
12.1.2 Hypertension Drugs Product Introduction
12.1.3 Pfizer Inc. Production, Value, Price, Gross Margin 2015-2020
12.2 XOMA LLC
12.2.1 XOMA LLC Basic Information
12.2.2 Hypertension Drugs Product Introduction
12.2.3 XOMA LLC Production, Value, Price, Gross Margin 2015-2020
12.3 Valeant Pharmaceuticals International Inc.
12.3.1 Valeant Pharmaceuticals International Inc. Basic Information
12.3.2 Hypertension Drugs Product Introduction
12.3.3 Valeant Pharmaceuticals International Inc. Production, Value, Price, Gross Margin 2015-2020
12.4 Daiichi Sankyo Co. Ltd.
12.4.1 Daiichi Sankyo Co. Ltd. Basic Information
12.4.2 Hypertension Drugs Product Introduction
12.4.3 Daiichi Sankyo Co. Ltd. Production, Value, Price, Gross Margin 2015-2020
12.5 Merck & Co. Inc
12.5.1 Merck & Co. Inc Basic Information
12.5.2 Hypertension Drugs Product Introduction
12.5.3 Merck & Co. Inc Production, Value, Price, Gross Margin 2015-2020
12.6 Boehringer Ingelheim GmbH
12.6.1 Boehringer Ingelheim GmbH Basic Information
12.6.2 Hypertension Drugs Product Introduction
12.6.3 Boehringer Ingelheim GmbH Production, Value, Price, Gross Margin 2015-2020
12.7 Bayer HealthCare
12.7.1 Bayer HealthCare Basic Information
12.7.2 Hypertension Drugs Product Introduction
12.7.3 Bayer HealthCare Production, Value, Price, Gross Margin 2015-2020
12.8 Sun Pharmaceutical Industries
12.8.1 Sun Pharmaceutical Industries Basic Information
12.8.2 Hypertension Drugs Product Introduction
12.8.3 Sun Pharmaceutical Industries Production, Value, Price, Gross Margin 2015-2020
12.9 Forest Laboratories Inc
12.9.1 Forest Laboratories Inc Basic Information
12.9.2 Hypertension Drugs Product Introduction
12.9.3 Forest Laboratories Inc Production, Value, Price, Gross Margin 2015-2020
12.10 Sanofi SA
12.10.1 Sanofi SA Basic Information
12.10.2 Hypertension Drugs Product Introduction
12.10.3 Sanofi SA Production, Value, Price, Gross Margin 2015-2020
12.11 Takeda Pharmaceuticals
12.11.1 Takeda Pharmaceuticals Basic Information
12.11.2 Hypertension Drugs Product Introduction
12.11.3 Takeda Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
12.12 Actelion Ltd
12.12.1 Actelion Ltd Basic Information
12.12.2 Hypertension Drugs Product Introduction
12.12.3 Actelion Ltd Production, Value, Price, Gross Margin 2015-2020
12.13 United Therapeutics Corp.
12.13.1 United Therapeutics Corp. Basic Information
12.13.2 Hypertension Drugs Product Introduction
12.13.3 United Therapeutics Corp. Production, Value, Price, Gross Margin 2015-2020
12.14 Bayer AG
12.14.1 Bayer AG Basic Information
12.14.2 Hypertension Drugs Product Introduction
12.14.3 Bayer AG Production, Value, Price, Gross Margin 2015-2020
12.15 Takeda Pharmaceutical Co. Ltd.
12.15.1 Takeda Pharmaceutical Co. Ltd. Basic Information
12.15.2 Hypertension Drugs Product Introduction
12.15.3 Takeda Pharmaceutical Co. Ltd. Production, Value, Price, Gross Margin 2015-2020
12.16 LG Life Sciences
12.16.1 LG Life Sciences Basic Information
12.16.2 Hypertension Drugs Product Introduction
12.16.3 LG Life Sciences Production, Value, Price, Gross Margin 2015-2020
12.17 Johnson & Johnson
12.17.1 Johnson & Johnson Basic Information
12.17.2 Hypertension Drugs Product Introduction
12.17.3 Johnson & Johnson Production, Value, Price, Gross Margin 2015-2020
12.18 AstraZeneca plc
12.18.1 AstraZeneca plc Basic Information
12.18.2 Hypertension Drugs Product Introduction
12.18.3 AstraZeneca plc Production, Value, Price, Gross Margin 2015-2020
12.19 Lupin Pharmaceuticals
12.19.1 Lupin Pharmaceuticals Basic Information
12.19.2 Hypertension Drugs Product Introduction
12.19.3 Lupin Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
12.20 Novartis AG
12.20.1 Novartis AG Basic Information
12.20.2 Hypertension Drugs Product Introduction
12.20.3 Novartis AG Production, Value, Price, Gross Margin 2015-2020
12.21 Beijing Tongrentang
12.21.1 Beijing Tongrentang Basic Information
12.21.2 Hypertension Drugs Product Introduction
12.21.3 Beijing Tongrentang Production, Value, Price, Gross Margin 2015-2020

13 Industry Outlook
13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release

14 Global Hypertension Drugs Market Forecast
14.1 Global Hypertension Drugs Market Value & Volume Forecast, by Type (2020-2025)
14.1.1 Calcium Channel Blockers Market Value and Volume Forecast (2020-2025)
14.1.2 Diuretics Market Value and Volume Forecast (2020-2025)
14.1.3 Beta Blockers Vasodilators Market Value and Volume Forecast (2020-2025)
14.1.4 Angiotensin Converting Enzyme Inhibitors Market Value and Volume Forecast (2020-2025)
14.1.5 Alpha Blockers Market Value and Volume Forecast (2020-2025)
14.1.6 Angiotensin Receptor Blockers Market Value and Volume Forecast (2020-2025)
14.1.7 Renin Inhibitors Market Value and Volume Forecast (2020-2025)
14.2 Global Hypertension Drugs Market Value & Volume Forecast, by Application (2020-2025)
14.2.1 Hospital use Market Value and Volume Forecast (2020-2025)
14.2.2 Clinic use Market Value and Volume Forecast (2020-2025)
14.2.3 Household Market Value and Volume Forecast (2020-2025)
14.3 Hypertension Drugs Market Analysis and Forecast by Region
14.3.1 North America Market Value and Consumption Forecast (2020-2025)
14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
14.3.5 South America Market Value and Consumption Forecast (2020-2025)

15 New Project Feasibility Analysis
15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter's Five Forces Analysis
15.1.2 New Entrants SWOT Analysis
15.2 Analysis and Suggestions on New Project Investment
?
List of Tables and Figures

Figure Product Picture of Hypertension Drugs
Table Product Specification of Hypertension Drugs
Table Hypertension Drugs Key Market Segments
Table Key Players Hypertension Drugs Covered
Figure Global Hypertension Drugs Market Size, 2015 - 2025
Table Different Types of Hypertension Drugs
Figure Global Hypertension Drugs Value ($) Segment by Type from 2015-2020
Figure Global Hypertension Drugs Market Share by Types in 2019
Table Different Applications of Hypertension Drugs
Figure Global Hypertension Drugs Value ($) Segment by Applications from 2015-2020
Figure Global Hypertension Drugs Market Share by Applications in 2019
Figure Global Hypertension Drugs Market Share by Regions in 2019
Figure North America Hypertension Drugs Production Value ($) and Growth Rate (2015-2020)
Figure Europe Hypertension Drugs Production Value ($) and Growth Rate (2015-2020)
Figure Asia Pacific Hypertension Drugs Production Value ($) and Growth Rate (2015-2020)
Figure Middle East and Africa Hypertension Drugs Production Value ($) and Growth Rate (2015-2020)
Figure South America Hypertension Drugs Production Value ($) and Growth Rate (2015-2020)
Table Global COVID-19 Status and Economic Overview
Figure Global COVID-19 Status
Figure COVID-19 Comparison of Major Countries
Figure Industry Chain Analysis of Hypertension Drugs
Table Upstream Raw Material Suppliers of Hypertension Drugs with Contact Information
Table Major Players Headquarters, and Service Area of Hypertension Drugs
Figure Major Players Production Value Market Share of Hypertension Drugs in 2019
Table Major Players Hypertension Drugs Product Types in 2019
Figure Production Process of Hypertension Drugs
Figure Manufacturing Cost Structure of Hypertension Drugs
Figure Channel Status of Hypertension Drugs
Table Major Distributors of Hypertension Drugs with Contact Information
Table Major Downstream Buyers of Hypertension Drugs with Contact Information
Table Global Hypertension Drugs Value ($) by Type (2015-2020)
Table Global Hypertension Drugs Value Share by Type (2015-2020)
Figure Global Hypertension Drugs Value Share by Type (2015-2020)
Table Global Hypertension Drugs Production by Type (2015-2020)
Table Global Hypertension Drugs Production Share by Type (2015-2020)
Figure Global Hypertension Drugs Production Share by Type (2015-2020)
Figure Global Hypertension Drugs Value ($) and Growth Rate of Calcium Channel Blockers (2015-2020)
Figure Global Hypertension Drugs Value ($) and Growth Rate of Diuretics (2015-2020)
Figure Global Hypertension Drugs Value ($) and Growth Rate of Beta Blockers Vasodilators (2015-2020)
Figure Global Hypertension Drugs Value ($) and Growth Rate of Angiotensin Converting Enzyme Inhibitors (2015-2020)
Figure Global Hypertension Drugs Value ($) and Growth Rate of Alpha Blockers (2015-2020)
Figure Global Hypertension Drugs Value ($) and Growth Rate of Angiotensin Receptor Blockers (2015-2020)
Figure Global Hypertension Drugs Value ($) and Growth Rate of Renin Inhibitors (2015-2020)
Figure Global Hypertension Drugs Price by Type (2015-2020)
Figure Downstream Market Overview
Table Global Hypertension Drugs Consumption by Application (2015-2020)
Table Global Hypertension Drugs Consumption Market Share by Application (2015-2020)
Figure Global Hypertension Drugs Consumption Market Share by Application (2015-2020)
Figure Global Hypertension Drugs Consumption and Growth Rate of Hospital use (2015-2020)
Figure Global Hypertension Drugs Consumption and Growth Rate of Clinic use (2015-2020)
Figure Global Hypertension Drugs Consumption and Growth Rate of Household (2015-2020)
Figure Global Hypertension Drugs Sales and Growth Rate (2015-2020)
Figure Global Hypertension Drugs Revenue (M USD) and Growth (2015-2020)
Table Global Hypertension Drugs Sales by Regions (2015-2020)
Table Global Hypertension Drugs Sales Market Share by Regions (2015-2020)
Table Global Hypertension Drugs Revenue (M USD) by Regions (2015-2020)
Table Global Hypertension Drugs Revenue Market Share by Regions (2015-2020)
Table Global Hypertension Drugs Revenue Market Share by Regions in 2015
Table Global Hypertension Drugs Revenue Market Share by Regions in 2019
Figure North America Hypertension Drugs Sales and Growth Rate (2015-2020)
Figure Europe Hypertension Drugs Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Hypertension Drugs Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Hypertension Drugs Sales and Growth Rate (2015-2020)
Figure South America Hypertension Drugs Sales and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure North America COVID-19 Confirmed Cases Major Distribution
Figure North America Hypertension Drugs Revenue (M USD) and Growth (2015-2020)
Table North America Hypertension Drugs Sales by Countries (2015-2020)
Table North America Hypertension Drugs Sales Market Share by Countries (2015-2020)
Table North America Hypertension Drugs Revenue (M USD) by Countries (2015-2020)
Table North America Hypertension Drugs Revenue Market Share by Countries (2015-2020)
Figure United States Hypertension Drugs Sales and Growth Rate (2015-2020)
Figure Canada Hypertension Drugs Sales and Growth Rate (2015-2020)
Figure Mexico Hypertension Drugs Sales and Growth (2015-2020)
Figure Europe COVID-19 Status
Figure Europe COVID-19 Confirmed Cases Major Distribution
Figure Europe Hypertension Drugs Revenue (M USD) and Growth (2015-2020)
Table Europe Hypertension Drugs Sales by Countries (2015-2020)
Table Europe Hypertension Drugs Sales Market Share by Countries (2015-2020)
Table Europe Hypertension Drugs Revenue (M USD) by Countries (2015-2020)
Table Europe Hypertension Drugs Revenue Market Share by Countries (2015-2020)
Figure Germany Hypertension Drugs Sales and Growth Rate (2015-2020)
Figure UK Hypertension Drugs Sales and Growth Rate (2015-2020)
Figure France Hypertension Drugs Sales and Growth (2015-2020)
Figure Italy Hypertension Drugs Sales and Growth (2015-2020)
Figure Spain Hypertension Drugs Sales and Growth (2015-2020)
Figure Russia Hypertension Drugs Sales and Growth (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Asia Pacific Hypertension Drugs Revenue (M USD) and Growth (2015-2020)
Table Asia Pacific Hypertension Drugs Sales by Countries (2015-2020)
Table Asia Pacific Hypertension Drugs Sales Market Share by Countries (2015-2020)
Table Asia Pacific Hypertension Drugs Revenue (M USD) by Countries (2015-2020)
Table Asia Pacific Hypertension Drugs Revenue Market Share by Countries (2015-2020)
Figure China Hypertension Drugs Sales and Growth Rate (2015-2020)
Figure Japan Hypertension Drugs Sales and Growth Rate (2015-2020)
Figure South Korea Hypertension Drugs Sales and Growth (2015-2020)
Figure India Hypertension Drugs Sales and Growth (2015-2020)
Figure Southeast Asia Hypertension Drugs Sales and Growth (2015-2020)
Figure Australia Hypertension Drugs Sales and Growth (2015-2020)
Figure Middle East Hypertension Drugs Revenue (M USD) and Growth (2015-2020)
Table Middle East Hypertension Drugs Sales by Countries (2015-2020)
Table Middle East and Africa Hypertension Drugs Sales Market Share by Countries (2015-2020)
Table Middle East and Africa Hypertension Drugs Revenue (M USD) by Countries (2015-2020)
Table Middle East and Africa Hypertension Drugs Revenue Market Share by Countries (2015-2020)
Figure Saudi Arabia Hypertension Drugs Sales and Growth Rate (2015-2020)
Figure UAE Hypertension Drugs Sales and Growth Rate (2015-2020)
Figure Egypt Hypertension Drugs Sales and Growth (2015-2020)
Figure Nigeria Hypertension Drugs Sales and Growth (2015-2020)
Figure South Africa Hypertension Drugs Sales and Growth (2015-2020)
Figure South America Hypertension Drugs Revenue (M USD) and Growth (2015-2020)
Table South America Hypertension Drugs Sales by Countries (2015-2020)
Table South America Hypertension Drugs Sales Market Share by Countries (2015-2020)
Table South America Hypertension Drugs Revenue (M USD) by Countries (2015-2020)
Table South America Hypertension Drugs Revenue Market Share by Countries (2015-2020)
Figure Brazil Hypertension Drugs Sales and Growth Rate (2015-2020)
Figure Argentina Hypertension Drugs Sales and Growth Rate (2015-2020)
Figure Columbia Hypertension Drugs Sales and Growth (2015-2020)
Figure Chile Hypertension Drugs Sales and Growth (2015-2020)
Figure Top 3 Market Share of Hypertension Drugs Companies in 2019
Figure Top 6 Market Share of Hypertension Drugs Companies in 2019
Table Major Players Production Value ($) Share (2015-2020)
Table Pfizer Inc. Profile
Table Pfizer Inc. Product Introduction
Figure Pfizer Inc. Production and Growth Rate
Figure Pfizer Inc. Value ($) Market Share 2015-2020
Table XOMA LLC Profile
Table XOMA LLC Product Introduction
Figure XOMA LLC Production and Growth Rate
Figure XOMA LLC Value ($) Market Share 2015-2020
Table Valeant Pharmaceuticals International Inc. Profile
Table Valeant Pharmaceuticals International Inc. Product Introduction
Figure Valeant Pharmaceuticals International Inc. Production and Growth Rate
Figure Valeant Pharmaceuticals International Inc. Value ($) Market Share 2015-2020
Table Daiichi Sankyo Co. Ltd. Profile
Table Daiichi Sankyo Co. Ltd. Product Introduction
Figure Daiichi Sankyo Co. Ltd. Production and Growth Rate
Figure Daiichi Sankyo Co. Ltd. Value ($) Market Share 2015-2020
Table Merck & Co. Inc Profile
Table Merck & Co. Inc Product Introduction
Figure Merck & Co. Inc Production and Growth Rate
Figure Merck & Co. Inc Value ($) Market Share 2015-2020
Table Boehringer Ingelheim GmbH Profile
Table Boehringer Ingelheim GmbH Product Introduction
Figure Boehringer Ingelheim GmbH Production and Growth Rate
Figure Boehringer Ingelheim GmbH Value ($) Market Share 2015-2020
Table Bayer HealthCare Profile
Table Bayer HealthCare Product Introduction
Figure Bayer HealthCare Production and Growth Rate
Figure Bayer HealthCare Value ($) Market Share 2015-2020
Table Sun Pharmaceutical Industries Profile
Table Sun Pharmaceutical Industries Product Introduction
Figure Sun Pharmaceutical Industries Production and Growth Rate
Figure Sun Pharmaceutical Industries Value ($) Market Share 2015-2020
Table Forest Laboratories Inc Profile
Table Forest Laboratories Inc Product Introduction
Figure Forest Laboratories Inc Production and Growth Rate
Figure Forest Laboratories Inc Value ($) Market Share 2015-2020
Table Sanofi SA Profile
Table Sanofi SA Product Introduction
Figure Sanofi SA Production and Growth Rate
Figure Sanofi SA Value ($) Market Share 2015-2020
Table Takeda Pharmaceuticals Profile
Table Takeda Pharmaceuticals Product Introduction
Figure Takeda Pharmaceuticals Production and Growth Rate
Figure Takeda Pharmaceuticals Value ($) Market Share 2015-2020
Table Actelion Ltd Profile
Table Actelion Ltd Product Introduction
Figure Actelion Ltd Production and Growth Rate
Figure Actelion Ltd Value ($) Market Share 2015-2020
Table United Therapeutics Corp. Profile
Table United Therapeutics Corp. Product Introduction
Figure United Therapeutics Corp. Production and Growth Rate
Figure United Therapeutics Corp. Value ($) Market Share 2015-2020
Table Bayer AG Profile
Table Bayer AG Product Introduction
Figure Bayer AG Production and Growth Rate
Figure Bayer AG Value ($) Market Share 2015-2020
Table Takeda Pharmaceutical Co. Ltd. Profile
Table Takeda Pharmaceutical Co. Ltd. Product Introduction
Figure Takeda Pharmaceutical Co. Ltd. Production and Growth Rate
Figure Takeda Pharmaceutical Co. Ltd. Value ($) Market Share 2015-2020
Table LG Life Sciences Profile
Table LG Life Sciences Product Introduction
Figure LG Life Sciences Production and Growth Rate
Figure LG Life Sciences Value ($) Market Share 2015-2020
Table Johnson & Johnson Profile
Table Johnson & Johnson Product Introduction
Figure Johnson & Johnson Production and Growth Rate
Figure Johnson & Johnson Value ($) Market Share 2015-2020
Table AstraZeneca plc Profile
Table AstraZeneca plc Product Introduction
Figure AstraZeneca plc Production and Growth Rate
Figure AstraZeneca plc Value ($) Market Share 2015-2020
Table Lupin Pharmaceuticals Profile
Table Lupin Pharmaceuticals Product Introduction
Figure Lupin Pharmaceuticals Production and Growth Rate
Figure Lupin Pharmaceuticals Value ($) Market Share 2015-2020
Table Novartis AG Profile
Table Novartis AG Product Introduction
Figure Novartis AG Production and Growth Rate
Figure Novartis AG Value ($) Market Share 2015-2020
Table Beijing Tongrentang Profile
Table Beijing Tongrentang Product Introduction
Figure Beijing Tongrentang Production and Growth Rate
Figure Beijing Tongrentang Value ($) Market Share 2015-2020
Table Market Driving Factors of Hypertension Drugs
Table Merger, Acquisition and New Investment
Table Global Hypertension Drugs Market Value ($) Forecast, by Type
Table Global Hypertension Drugs Market Volume Forecast, by Type
Figure Global Hypertension Drugs Market Value ($) and Growth Rate Forecast of Calcium Channel Blockers (2020-2025)
Figure Global Hypertension Drugs Market Volume ($) and Growth Rate Forecast of Calcium Channel Blockers (2020-2025)
Figure Global Hypertension Drugs Market Value ($) and Growth Rate Forecast of Diuretics (2020-2025)
Figure Global Hypertension Drugs Market Volume ($) and Growth Rate Forecast of Diuretics (2020-2025)
Figure Global Hypertension Drugs Market Value ($) and Growth Rate Forecast of Beta Blockers Vasodilators (2020-2025)
Figure Global Hypertension Drugs Market Volume ($) and Growth Rate Forecast of Beta Blockers Vasodilators (2020-2025)
Figure Global Hypertension Drugs Market Value ($) and Growth Rate Forecast of Angiotensin Converting Enzyme Inhibitors (2020-2025)
Figure Global Hypertension Drugs Market Volume ($) and Growth Rate Forecast of Angiotensin Converting Enzyme Inhibitors (2020-2025)
Figure Global Hypertension Drugs Market Value ($) and Growth Rate Forecast of Alpha Blockers (2020-2025)
Figure Global Hypertension Drugs Market Volume ($) and Growth Rate Forecast of Alpha Blockers (2020-2025)
Figure Global Hypertension Drugs Market Value ($) and Growth Rate Forecast of Angiotensin Receptor Blockers (2020-2025)
Figure Global Hypertension Drugs Market Volume ($) and Growth Rate Forecast of Angiotensin Receptor Blockers (2020-2025)
Figure Global Hypertension Drugs Market Value ($) and Growth Rate Forecast of Renin Inhibitors (2020-2025)
Figure Global Hypertension Drugs Market Volume ($) and Growth Rate Forecast of Renin Inhibitors (2020-2025)
Table Global Market Value ($) Forecast by Application (2020-2025)
Table Global Market Volume Forecast by Application (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Hospital use (2020-2025)
Figure Market Volume and Growth Rate Forecast of Hospital use (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Clinic use (2020-2025)
Figure Market Volume and Growth Rate Forecast of Clinic use (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Household (2020-2025)
Figure Market Volume and Growth Rate Forecast of Household (2020-2025)
Figure North America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure North America Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Europe Consumption and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure South America Consumption and Growth Rate Forecast (2020-2025)
Figure Porter's Five Forces Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
  • Global Pulmonary Arterial Hypertension (Pah) Medicine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Pulmonary Arterial Hypertension (Pah) Medicine market: According to our latest research, the global Pulmonary Arterial Hypertension (Pah) Medicine market looks promising in the next 5 years. As of 2022, the global Pulmonary Arterial Hypertension (Pah) Medicine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to ......
  • Global Nifedipine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 102
    Market Overview of Global Nifedipine market: According to our latest research, the global Nifedipine market looks promising in the next 5 years. As of 2022, the global Nifedipine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Nifedipine market, with a systematical de......
  • Global Amlodipine Besylate Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 115
    The Amlodipine Besylate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amlodipine Besylate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profil......
  • Pulmonary Arterial Hypertension (PAH) Drugs - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 112
    The global Pulmonary Arterial Hypertension (PAH) Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pulmonary Arterial Hypertension (PAH) Drugs in various end use industries. The expanding demands from the Hospitals, Clinics and Other,, are propelling Pulmonary Arterial Hypertension (PAH) Drugs market. Inhalation, one of the segments analysed in this report, is projected to record % ......
  • Captopril API - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 100
    The global Captopril API market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Captopril API in various end use industries. The expanding demands from the Captopril Tablet, Compound Captopril Tablet and Captopril Injection,, are propelling Captopril API market. 98% Captopril API, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the......
  • Telmisartan - Global Market Insights and Sales Trends 2024
    Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 107
    The global Telmisartan market size is expected to reach US$ 3631.3 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Telmisartan in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Telmisartan market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-Dried......
  • Global Ambrisentan Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 106
    Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......
  • Global Ambrisentan Market Research Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 2680 Onwards        Pages: 132
    Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......
  • Global Amlodipine Besylate Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 133
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs